Visus Therapeutics rakes in $36m

Visus Therapeutics Inc, a developer of eye drops, has raised $36 million in funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this